Voloridge Investment Management, LLC Cyma Bay Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.47 - $10.95 $1.95 Million - $2.86 Million	-261,340 Reduced 40.59%	382,472 $4.19 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $3.79 Million - $6.17 Million	643,812 New	643,812 $5.61 Million
Q1 2021 May 17, 2021	SELL	$4.23 - $6.55 $827,544 - $1.28 Million	-195,637 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $1.13 Million - $1.78 Million	-197,275 Reduced 50.21%	195,637 $1.12 Million
Q3 2020 Nov 16, 2020	BUY	$3.32 - $7.24 $1.3 Million - $2.84 Million	392,912 New	392,912 $2.85 Million
Q2 2020 Aug 14, 2020	SELL	$1.41 - $4.25 $48,680 - $146,731	-34,525 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.25 - $2.02 $71,667 - $115,814	-57,334 Reduced 62.42%	34,525 $51,000
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $36,532 - $162,885	27,468 Added 42.66%	91,859 $180,000
Q3 2019 Nov 14, 2019	BUY	$5.12 - $7.21 $329,681 - $464,259	64,391 New	64,391 $330,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.